Taebo Sim

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 12

Top Venues

Journal of medicinal chemistry

ACS chemical biology

The Journal of organic chemistry

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

SeongShick Ryu, Jung-Eun Park, Young Jin Ham, Daniel C Lim, Nicholas P Kwiatkowski, Do-Hee Kim, Debabrata Bhunia, Nam Doo Kim, Michael B Yaffe, Woolim Son, Namkyoung Kim, Tae-Ik Choi, Puspanjali Swain, Cheol-Hee Kim, Jin-Young Lee, Nathanael S Gray, Kyung S Lee, Taebo Sim
Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1. Journal of medicinal chemistry 65 (3) (2022)
SeongShick Ryu, Yunju Nam, Namkyoung Kim, Injae Shin, Eunhye Jeon, Younghoon Kim, Nam Doo Kim, Taebo Sim
Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug Resistance. Journal of medicinal chemistry 65 (8) (2022)
Hanna Cho, Injae Shin, Hojong Yoon, Eunhye Jeon, Jiwon Lee, Younghoon Kim, SeongShick Ryu, Chiman Song, Nam Hoon Kwon, Youngji Moon, Sunghoon Kim, Nam Doo Kim, Hwan Geun Choi, Taebo Sim
Identification of Thieno[3,2-d]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3. Journal of medicinal chemistry 64 (16) (2021)
Magda Bahcall, Cloud P Paweletz, Yanan Kuang, Luke J Taus, Taebo Sim, Nam Doo Kim, Kshiti H Dholakia, Christie J Lau, Prafulla C Gokhale, Pratik R Chopade, Fangxin Hong, Zihan Wei, Jens Köhler, Paul T Kirschmeier, Jiannan Guo, Sujuan Guo, Stephen Wang, Pasi A Janne
Combination of type I and type II MET tyrosine kinase inhibitors as therapeutic approach to prevent resistance. Molecular cancer therapeutics (2021)
Youngsun Han, Sandip Sengupta, Byung Joo Lee, Hanna Cho, Jiknyeo Kim, Hwan Geun Choi, Uttam Dash, Jin Hyoung Kim, Nam Doo Kim, Jeong Hun Kim, Taebo Sim
Identification of a Unique Resorcylic Acid Lactone Derivative That Targets Both Lymphangiogenesis and Angiogenesis. Journal of medicinal chemistry 62 (20) (2019)
Hanna Cho, Injae Shin, Kyungseon Cho, Hojong Yoon, Eun Kyung Yoo, Mi-Jin Kim, Sungmi Park, In-Kyu Lee, Nam Doo Kim, Taebo Sim
Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors. Journal of medicinal chemistry 62 (18) (2019)
Chiman Song, Namkyoung Kim, Miri Park, Jiyeon Lee, Ki-Bong Oh, Taebo Sim
Procaspase activating compound 1 controls tetracycline repressor-regulated gene expression system. Bioscience reports 39 (1) (2019)
Jinhua Wang, Tatiana Erazo, Fleur M Ferguson, Dennis L Buckley, Nestor Gomez, Pau Muñoz-Guardiola, Nora Diéguez-Martínez, Xianming Deng, Mingfeng Hao, Walter Massefski, Oleg Fedorov, Nana Kwaku Offei-Addo, Paul M C Park, Lingling Dai, Amy DiBona, Kelly Becht, Nam Doo Kim, Michael R McKeown, Justin M Roberts, Jinwei Zhang, Taebo Sim, Dario R Alessi, James E Bradner, Jose M Lizcano, Stephen C Blacklow, Jun Qi, Xiang Xu, Nathanael S Gray
Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains. ACS chemical biology 13 (9) (2018)
Hanna Cho, Injae Shin, Eunhye Ju, Seunghye Choi, Wooyoung Hur, Haelee Kim, Eunmi Hong, Nam Doo Kim, Hwan Geun Choi, Nathanael S Gray, Taebo Sim
First SAR Study for Overriding NRAS Mutant Driven Acute Myeloid Leukemia. Journal of medicinal chemistry 61 (18) (2018)
Eun-Kyoung Bang, Hanna Cho, Sean S-H Jeon, Na Ly Tran, Dong-Kwon Lim, Wooyoung Hur, Taebo Sim
Amphiphilic small peptides for delivery of plasmid DNAs and siRNAs. Chemical biology & drug design 91 (2) (2017)
Sandip Sengupta, Munhyung Bae, Dong-Chan Oh, Uttam Dash, Hak Joong Kim, Woon Young Song, Injae Shin, Taebo Sim
Structural Revision of Baulamycin A and Structure-Activity Relationships of Baulamycin A Derivatives. The Journal of organic chemistry 82 (24) (2017)
Hanna Cho, Sandip Sengupta, Sean S H Jeon, Wooyoung Hur, Hwan Geun Choi, Hong-Seog Seo, Byung Joo Lee, Jeong Hun Kim, Minhwan Chung, Noo Li Jeon, Nam Doo Kim, Taebo Sim
Identification of the First Selective Activin Receptor-Like Kinase 1 Inhibitor, a Reversible Version of L-783277. Journal of medicinal chemistry 60 (4) (2017)

Taebo Sim.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Taebo Sim